Article EMA Thank You EMA finalizes clinical anticancer therapeutic guidance update
Agency IQ
FEBRUARY 2, 2024
The protocol and statistical analysis plan should clearly specify the plans for specimen collection, sample analysis and related clinical outcomes depending on the biomarker assay development and validation strategy.
Let's personalize your content